PartsTable TECHNICAL DATA SHEET
NSN 6505-01-650-2681Government record, cited

Lorazepam Injection6505-01-650-2681

NSN 6505-01-650-2681 · NIIN 016502681
FSC 6505 — Drugs and Biologicals · FSG 65 — Medical, Dental, and Veterinary Equipment
Government record, cited
Also searched as  6505-01-650-2681 · 6505016502681 · NIIN 016502681 · 01-650-2681 · FSC 6505 Drugs and Biologicals · 6505NCM152484 · 1389508 · NDC00409-6778-02
Nearby stock numbers  ·
Features
  • Lorazepam Injection — FSC 6505
  • Controlled Substance Classification: SCHEDULE IV
  • Administration: INTRAVENOUS AND INTRAMUSCULAR
  • Primary Container Content Quantity: 2.0 MILLILITERS
  • Medical Designation and Grade: UNITED STATES PHARMACOPEIA
  • Primary Container Type: VIAL
  • Protective Storage Feature: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
  • Pharmaceutical Vehicle Type: AQUEOUS
Identification
  • NSN: 6505-01-650-2681
  • NIIN: 016502681
  • FSC: 6505 — Drugs and Biologicals
  • FSG: 65 — Medical, Dental, and Veterinary Equipment
General Description

The Lorazepam Injection, cataloged under National Stock Number 6505-01-650-2681, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. Government technical data includes 9 specifications, cited from the U.S. Government catalog. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.

Catalog Facts
Item NameLorazepam Injection
FSC / FSG6505 — Drugs and Biologicals (FSG 65)
Technical Specifications
ParameterValue
NSN6505-01-650-2681
Item NameLorazepam Injection
FSC / FSG6505 / 65 — Drugs and Biologicals
StatusACTIVE
Controlled Substance ClassificationSCHEDULE IV
AdministrationINTRAVENOUS AND INTRAMUSCULAR
Primary Container Content Quantity2.0 MILLILITERS
Medical Designation and GradeUNITED STATES PHARMACOPEIA
Primary Container TypeVIAL
Protective Storage FeatureREQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
Pharmaceutical Vehicle TypeAQUEOUS
Active Medicament Medicinal Strength2.0 MILLIGRAMS LORAZEPAM PER MILLIGRAM
Total Primary Container Quantity10
Lifecycle & Compliance
Acquisition StatusACTIVE
DEMIL CodeDEMIL A — No Demilitarization Required
HazardPossible hazard — SDS may be required (DLA HMIC P)
Criticality CodeX
Unit of IssuePG
Cross-Reference Index
No manufacturer part numbers on file in the U.S. Government catalog.
Reference documents
ReferenceMeaning
6505NCM152484 5/1 Secondary reference
Defense Medical Standardization Board
1389508 5/1 Secondary reference
U.S. Government activity
NDC00409-6778-02 3/2 Design control — primary reference
U.S. Government activity

Frequently Asked Questions

What is NSN 6505-01-650-2681?

NSN 6505-01-650-2681 is a Lorazepam Injection, classified under FSC 6505, Drugs and Biologicals. Status: active.

What are the specifications of 6505-01-650-2681?

Key specifications for 6505-01-650-2681: Controlled Substance Classification: SCHEDULE IV; Administration: INTRAVENOUS AND INTRAMUSCULAR; Primary Container Content Quantity: 2.0 MILLILITERS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA. 9 specifications are documented in the U.S. Government catalog.

Is NSN 6505-01-650-2681 hazardous material?

Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.

Sources

U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.

U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.

✓ Data cited from the U.S. Government catalog; commercial cross-references from OEM and certified industry sources.
PartsTable Design LLC · partstable.com